BeiGene

$308.27
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$6.35 (-2.02%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell BeiGene and other stocks, options, and ETFs commission-free!

About BGNE

BeiGene, Ltd. American Depositary Shares, also called BeiGene, is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer.

CEO
John V. Oyler
Employees
5,300
Headquarters
Beijing, Beijing
Founded
2010
Market Cap
31.99B
Price-Earnings Ratio
Dividend Yield
Average Volume
235.14K
High Today
$313.00
Low Today
$302.99
Open Price
$313.00
Volume
157.81K
52 Week High
$388.97
52 Week Low
$136.48

BGNE Earnings

-$6.39
-$4.26
-$2.13
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
per share
Actual
Expected May 10

You May Also Like

SPTKW
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure